In addition, we identified sphingosine kinase 1 (SPHK1) as a novel target of miR-506, the expression of which inhibited the SPHK1/Akt/NF-κB signaling pathway, which is activated in PC [48]. The gene discussed is SPHK1; the disease is pachyonychia congenita.